ENDRA Life Sciences Return on Tangible Equity 2017-2024 | NDRA
Current and historical return on tangible equity values for ENDRA Life Sciences (NDRA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ENDRA Life Sciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-06-30 | $-0.01B | $0.01B | -150.00% |
| 2024-03-31 | $-0.01B | $0.00B | -181.82% |
| 2023-12-31 | $-0.01B | $0.01B | -181.82% |
| 2023-09-30 | $-0.01B | $0.01B | -208.70% |
| 2023-06-30 | $-0.01B | $0.01B | -171.43% |
| 2023-03-31 | $-0.01B | $0.00B | -152.94% |
| 2022-12-31 | $-0.01B | $0.01B | -133.33% |
| 2022-09-30 | $-0.01B | $0.01B | -120.93% |
| 2022-06-30 | $-0.01B | $0.01B | -113.04% |
| 2022-03-31 | $-0.01B | $0.01B | -100.00% |
| 2021-12-31 | $-0.01B | $0.01B | -77.19% |
| 2021-09-30 | $-0.01B | $0.01B | -75.47% |
| 2021-06-30 | $-0.01B | $0.02B | -102.33% |
| 2021-03-31 | $-0.01B | $0.02B | -151.72% |
| 2020-12-31 | $-0.01B | $0.01B | -342.86% |
| 2020-09-30 | $-0.02B | $0.00B | -633.33% |
| 2020-06-30 | $-0.02B | $0.00B | -720.00% |
| 2020-03-31 | $-0.02B | $0.00B | -618.18% |
| 2019-12-31 | $-0.02B | $0.01B | -566.67% |
| 2019-09-30 | $-0.01B | $0.00B | -307.69% |
| 2019-06-30 | $-0.01B | $0.00B | -333.33% |
| 2019-03-31 | $-0.01B | $0.00B | -333.33% |
| 2018-12-31 | $-0.01B | $0.01B | -363.64% |
| 2018-09-30 | $-0.01B | $0.00B | -400.00% |
| 2018-06-30 | $-0.01B | $0.00B | -188.24% |
| 2018-03-31 | $-0.01B | $0.00B | -121.74% |
| 2017-12-31 | $-0.01B | $0.01B | -105.26% |
| 2017-09-30 | $-0.00B | $0.01B | -123.08% |
| 2017-06-30 | $-0.00B | $0.01B | -266.67% |
| 2017-03-31 | $-0.00B | $-0.00B | 800.00% |
| 2016-12-31 | $-0.00B | $-0.00B | 1200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.004B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.603B | 28.12 |
| Intuitive Surgical (ISRG) | United States | $174.618B | 98.87 |
| Alcon (ALC) | Switzerland | $48.644B | 34.24 |
| IQVIA Holdings (IQV) | United States | $43.639B | 24.73 |
| IDEXX Laboratories (IDXX) | United States | $42.090B | 50.63 |
| Edwards Lifesciences (EW) | United States | $41.782B | 26.78 |
| DexCom (DXCM) | United States | $28.087B | 40.05 |
| STERIS (STE) | Ireland | $24.036B | 28.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.526B | 0.00 |
| Waters (WAT) | United States | $19.509B | 29.08 |
| Hologic (HOLX) | United States | $19.209B | 20.88 |
| Sysmex ADR (SSMXY) | Japan | $12.323B | 38.64 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.282B | 13.77 |
| Teleflex (TFX) | United States | $11.593B | 18.03 |
| Globus Medical (GMED) | United States | $9.474B | 26.50 |
| Penumbra (PEN) | United States | $7.289B | 75.67 |
| Glaukos (GKOS) | United States | $6.829B | 0.00 |
| Masimo (MASI) | United States | $6.063B | 32.47 |
| TransMedics (TMDX) | United States | $5.044B | 216.01 |
| Integer Holdings (ITGR) | United States | $4.288B | 25.07 |
| PROCEPT BioRobotics (PRCT) | United States | $4.258B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.795B | 0.00 |
| Inari Medical (NARI) | United States | $2.695B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.649B | 15.54 |
| Nihon Kohden (NHNKY) | Japan | $2.633B | 16.38 |
| Veracyte (VCYT) | United States | $2.583B | 160.14 |
| Elekta AB (EKTAY) | Sweden | $2.438B | 19.86 |
| RxSight (RXST) | United States | $2.054B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.344B | 6.12 |
| Pulse Biosciences (PLSE) | United States | $1.250B | 0.00 |
| OPKO Health (OPK) | United States | $1.144B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.117B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.112B | 19.84 |
| Artivion (AORT) | United States | $1.063B | 97.61 |
| Alphatec Holdings (ATEC) | United States | $0.830B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.665B | 16.80 |
| SiBone (SIBN) | United States | $0.647B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.631B | 0.00 |
| AxoGen (AXGN) | United States | $0.626B | 0.00 |
| IRadimed (IRMD) | United States | $0.622B | 33.60 |
| Paragon 28 (FNA) | United States | $0.590B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.504B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.332B | 10.14 |
| Treace Medical Concepts (TMCI) | United States | $0.312B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.302B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.264B | 0.00 |
| Inogen (INGN) | United States | $0.260B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Nevro (NVRO) | United States | $0.215B | 0.00 |
| NeuroPace (NPCE) | United States | $0.204B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.178B | 12.46 |
| CVRx (CVRX) | United States | $0.167B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.120B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.110B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.100B | 14.93 |
| Hyperfine (HYPR) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Envoy Medical (COCH) | United States | $0.065B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
| LENSAR (LNSR) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.040B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Neuronetics (STIM) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |